Detalhe da pesquisa
1.
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection.
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32393496
2.
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910894
3.
Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133549
4.
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers.
Antimicrob Agents Chemother
; 61(8)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28559255
5.
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807912
6.
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872061
7.
Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers.
Antimicrob Agents Chemother
; 60(9): 5437-44, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27381392
8.
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin.
J Hepatol
; 62(2): 294-302, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239078
9.
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.
Antimicrob Agents Chemother
; 59(8): 4919-29, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055360
10.
Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat".
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269431
11.
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection.
Open Forum Infect Dis
; 9(2): ofab630, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106315
12.
Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection.
J Clin Pharmacol
; 60(11): 1509-1518, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32621543
13.
Development and implementation of clinical trial protocol templates at the National Institute of Allergy and Infectious Diseases.
Clin Trials
; 6(4): 386-91, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19625326
14.
Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients.
Open Forum Infect Dis
; 6(2): ofz003, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30775403
15.
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
J Clin Invest
; 115(8): 2139-48, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16025158
16.
Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.
Clin Pharmacokinet
; 57(3): 367-377, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639229
17.
A randomized trial comparing concise and standard consent forms in the START trial.
PLoS One
; 12(4): e0172607, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445471
18.
Post-trial access to tested interventions: the views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study.
AIDS Res Hum Retroviruses
; 22(9): 837-41, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16989607
19.
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.
Hum Gene Ther
; 16(9): 1065-74, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16149905
20.
Therapeutic use of interleukin-2 in HIV-infected patients.
Curr Opin Pharmacol
; 2(4): 433-9, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12127877